Rachel L. Sher

Registered Lobbyist
Disclosed Prior Position
Senior Policy Analyst, Food and Drug Administration; Senior FDA Counsel, Energy and Commerce Committee; FDA Counsel, U.S. Representative Henry Waxman
Lobby Filings
6
Clients
1
Firms
1
Years Active
2019–2020
Total Contributed
$0
Contributions
0
Recipients
0
Contrib Filings
4
Top Recipient Legislators
No matched legislators.

Lobbying Filings

All 2020 2019
YearFirmClientIncomeDoc
2020
2nd Quarter - Report		 NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (N… NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NOR… —
2020
1st Quarter - Report		 NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (N… NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NOR… —
2019
4th Quarter - Report		 NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (N… NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NOR… —
2019
3rd Quarter - Report		 NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (N… NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NOR… —
2019
2nd Quarter - Report		 NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (N… NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NOR… —
2019
1st Quarter - Report		 NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (N… NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NOR… —

Political Contributions

No contributions found for this lobbyist.

Contribution Filings (LD-203)

YearPeriodPostedStatusDoc
2020 Year End Feb 1, 2021 None
2020 Mid Year Jul 30, 2020 None
2019 Year End Jan 22, 2020 None
2019 Mid Year Jul 15, 2019 None